Kane Biotech IncTSXV:KNEView on OTCQB
- LAST PRICE0.1050
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots0.1050/ 12
- Ask / Lots0.1100/ 26
- Open / Previous Close0.1150 / 0.1050
- Day Range
- 52 Week Range
- Volume97,111
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | KNE |
|---|---|---|
| 09:44 ET | 13500 | 0.115 |
| 09:46 ET | 2000 | 0.11 |
| 11:59 ET | 60500 | 0.105 |
| 12:48 ET | 2000 | 0.11 |
| 02:38 ET | 19000 | 0.105 |
Nov 14, 2024
Kane Biotech Announces Health Canada Approval of revyve(TM) Antimicrobial Wound Gel, from 1:10PM ET on Thursday Nov 14, 2024 by Dow Jones
1:10PM ET on Thursday Nov 14, 2024 by Dow JonesKane Biotech Provides Investor Update Following FB Dermatology Acquisition Announcement, from 8:30AM ET on Thursday Nov 14, 2024 by Dow Jones
8:30AM ET on Thursday Nov 14, 2024 by Dow Jones
Nov 12, 2024
Canadian Investment Regulatory Organization Trade Resumption - KNE, from 1:27PM ET on Tuesday Nov 12, 2024 by Dow Jones
1:27PM ET on Tuesday Nov 12, 2024 by Dow JonesKane Biotech Announces Agreement to Acquire FB Dermatology, from 1:08PM ET on Tuesday Nov 12, 2024 by Dow Jones
1:08PM ET on Tuesday Nov 12, 2024 by Dow JonesCanadian Investment Regulatory Organization Trading Halt - KNE, from 1:01PM ET on Tuesday Nov 12, 2024 by Dow Jones
1:01PM ET on Tuesday Nov 12, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Kane Biotech Inc | 13.8M | -2.5x | --- |
Cytophage Technologies Ltd | 13.5M | -0.8x | --- |
Preveceutical Medical Inc | 10.8M | -8.5x | --- |
Voyageur Pharmaceuticals Ltd | 9.1M | -6.3x | --- |
Pharmather Holdings Ltd | 19.0M | -9.0x | --- |
Mojave Brands Inc | 7.0M | -5.6x | --- |
Company Information
Kane Biotech Inc. is a Canada-based biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The Company has a portfolio of biotechnologies, intellectual property (66 patents and patents pending, trade secrets and trademarks) and products developed by its own biofilm research expertise and acquired from research institutions. DispersinB, coactiv+, coactiv+, DermaKB, DermaKB Biofilm, and revive are trademarks of the Company. Its patented coactiv+ technology is specifically formulated to destabilize biofilm and create an environment for fast wound healing. In Wound Care & Surgical applications, in addition to revyve Antimicrobial Wound Gel, it is developing follow-on products with three applications: coactiv+ Antimicrobial Surgical Hydrogel, coactiv+ Antimicrobial Wound Gel Spray, and coactiv+ Antimicrobial Wound Rinse. The Company's other biofilm disruption technology is DispersinB.
Contact Information
- Headquarters
- 290-100 Innovation DriveWINNIPEG, MB, Canada R3T 6G2
- Phone
- 204-453-1301
- Fax
- 204-474-7552
Executives
- Chairman of the Board
- Philip Renaud
- President, Chief Executive Officer, Director
- Marc Edwards
- Chief Financial Officer
- Raymond Dupuis
- Vice President - Quality & Compliance
- Lori Christofalos
- Director of Marketing
- Wendy Nachtigall
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $13.8M |
|---|---|
Revenue (TTM) | $757.1K |
Shares Outstanding | 131.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.47 |
EPS | $-0.04 |
Book Value | $-0.08 |
P/E Ratio | -2.5x |
Price/Sales (TTM) | 18.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -597.09% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
